Clinical Trial Update: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 clinical trial program evaluating stratified medicine approaches for rifampicin-resistant tuberculosis, including pulmonary MDR tubercul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis

Snippet

Sponsor: University of California, San Francisco | Conditions: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant | Phase 2, Phase 3 | Status: RECRUITING